Blood clotting is your body’s emergency repair system. When a blood vessel is damaged, a series of rapid chemical reactions seal the wound, stop bleeding, and prevent dangerous blood loss. The entire process, called hemostasis, involves blood vessel walls, cell fragments called platelets, and dozens of proteins working together in a precise sequence. A normal clot forms in minutes and dissolves on its own once healing is complete, but problems with this system can lead to excessive bleeding or dangerous clots that block blood flow.
The Three Stages of Clot Formation
Clotting happens in three overlapping stages, each building on the last. The speed is remarkable: the first stage kicks in within about 30 seconds of an injury.
Stage 1: Blood vessel constriction. The moment a blood vessel is damaged, the muscles in its wall tighten, narrowing the vessel and slowing blood flow to the injured area. This buys time for the next steps. It also exposes the inner structural layer of the vessel wall, which acts as a chemical signal that attracts platelets to the scene.
Stage 2: Platelet plug. Platelets are tiny cell fragments circulating in your blood. A healthy adult has between 150,000 and 450,000 of them per microliter. When they detect an exposed vessel wall, they stick to the injury site and to each other. Once attached, they change shape, sprouting arm-like extensions that help them link together more tightly. They also release chemical signals that recruit even more platelets, quickly building a soft, temporary plug over the wound.
Stage 3: The clotting cascade. The platelet plug is fragile on its own. To reinforce it, your blood launches a chain reaction involving more than a dozen clotting proteins (called clotting factors). The end goal of this entire chain is to produce a protein called thrombin, which converts a dissolved blood protein called fibrinogen into solid fibrin strands. These fibrin strands weave through the platelet plug like threads through fabric, creating a tough, stable mesh that holds everything in place until the tissue underneath heals.
How the Clotting Cascade Works
The chain reaction that produces fibrin can start through two different triggers, often called the extrinsic and intrinsic pathways. Both converge on the same final steps.
The extrinsic pathway is the faster route. It begins when damaged tissue releases a substance called tissue factor, which activates a series of clotting proteins in rapid succession. The intrinsic pathway starts when blood itself comes into contact with the exposed inner wall of a damaged vessel, triggering a separate but overlapping set of proteins. Both pathways ultimately produce the same result: thrombin generation, fibrinogen conversion to fibrin, and a stabilized clot.
Once the fibrin mesh forms, another clotting factor cross-links the fibrin strands together, making the clot contract and pull the wound edges closer. This is why a small cut stops bleeding and begins to close relatively quickly.
What Your Body Needs to Clot Properly
Vitamin K plays a central role. Your liver uses it to manufacture several essential clotting factors, including four that directly promote clotting and two natural anticoagulant proteins that keep clotting from going too far. Without enough vitamin K, from diet, supplements, or gut bacteria that produce it, your body can’t make these factors efficiently, and bleeding becomes harder to stop.
Calcium is also required at multiple points in the cascade. And because the liver produces most clotting factors, liver disease can significantly impair your body’s ability to form clots.
When Clotting Goes Wrong
The system can fail in two directions: too little clotting or too much.
Too little clotting means wounds bleed longer than normal, bruises appear easily, or internal bleeding occurs without obvious injury. This can result from low platelet counts, vitamin K deficiency, liver disease, or inherited conditions like hemophilia where specific clotting factors are missing or defective.
Too much clotting, called hypercoagulability, means clots form inside blood vessels when they shouldn’t. Genetic factors account for up to 30% of abnormal venous clots and are most commonly caused by two inherited mutations: one that makes a clotting factor resistant to being switched off, and another that leads to elevated levels of a clot-promoting protein. Rarer inherited conditions involve deficiencies in natural anticoagulant proteins, which affect roughly 1% of the population but carry a significantly higher clot risk.
Acquired risk factors are even more common. Surgery, pregnancy, hormonal therapies including birth control pills, cancer, infections, and prolonged immobility all shift the balance toward excessive clotting. Cancer is the second most common acquired cause, because tumor cells can produce substances that directly activate the clotting system. The most common acquired clotting disorder overall is antiphospholipid syndrome, an autoimmune condition affecting 3% to 5% of the population in which the immune system attacks components of cell membranes, increasing the risk of both arterial and venous clots.
Signs of a Dangerous Blood Clot
The most common location for a dangerous internal clot is in the deep veins of the legs, a condition called deep vein thrombosis (DVT). Symptoms include leg swelling, pain or cramping that often starts in the calf, skin that turns red or purple, and a feeling of warmth in the affected area. Some DVTs cause no symptoms at all.
The greatest danger from a DVT is that the clot breaks loose, travels through the heart, and lodges in the lungs. This is a pulmonary embolism, and it can be life-threatening. Warning signs include sudden shortness of breath that worsens with activity, sharp chest pain that intensifies when you breathe deeply, rapid or irregular heartbeat, coughing up blood-streaked mucus, dizziness, and fainting. These symptoms require emergency medical attention.
How Clotting Is Measured
Doctors use simple blood tests to evaluate how well your clotting system works. A prothrombin time (PT) test measures how quickly the extrinsic pathway functions, with normal results falling between 9 and 13 seconds. A partial thromboplastin time (PTT) test evaluates the intrinsic pathway, with normal values between 25 and 35 seconds. Longer times in either test suggest a problem with specific clotting factors or the presence of a blood-thinning medication. A complete blood count reveals your platelet number, and results below 150,000 per microliter indicate a condition called thrombocytopenia.
How Blood-Thinning Medications Work
Medications that reduce clotting fall into two categories, and they work in fundamentally different ways.
Antiplatelet drugs, like aspirin, prevent platelets from clumping together in the first place. They’re primarily used for conditions involving arterial clots, such as after a heart attack or stroke, because arterial clots are largely platelet-driven. Anticoagulants, on the other hand, interfere with the clotting cascade itself, slowing down the chain reaction that produces fibrin. These are used for conditions like atrial fibrillation or after a DVT, where clots form in slower-moving venous blood and depend more heavily on the protein cascade.
The distinction matters because the wrong type of blood thinner for a given condition may not provide adequate protection. In some high-risk situations, such as when a patient has both atrial fibrillation and a recently placed heart stent, doctors use both types together, carefully balancing clot prevention against the increased risk of bleeding.